Mitigating cellular aging and enhancing cognitive functionality: visual arts-mediated Cognitive Activation Therapy in neurocognitive disorders
- PMID: 38524114
- PMCID: PMC10957554
- DOI: 10.3389/fnagi.2024.1354025
Mitigating cellular aging and enhancing cognitive functionality: visual arts-mediated Cognitive Activation Therapy in neurocognitive disorders
Abstract
The growing phenomenon of population aging is redefining demographic dynamics, intensifying age-related conditions, especially dementia, projected to triple by 2050 with an enormous global economic burden. This study investigates visual arts-mediated Cognitive Activation Therapy (CAT) as a non-pharmacological CAT intervention targets both biological aging [leukocyte telomere length (LTL), DNA methylation age (DNAmAge)] and cognitive functionality. Aligning with a broader trend of integrating non-pharmacological approaches into dementia care. The longitudinal study involved 20 patients with mild to moderate neurocognitive disorders. Cognitive and functional assessments, and biological aging markers -i.e., LTL and DNAmAge- were analyzed before and after CAT intervention. Change in LTL was positively correlated with days of treatment (p =0.0518). LTL significantly elongated after intervention (p =0.0269), especially in men (p =0.0142), correlating with younger age (p =0.0357), and higher education (p =0.0008). DNAmAge remained instead stable post-treatment. Cognitive and functional improvements were observed for Copy of complex geometric figure, Progressive Silhouettes, Position Discrimination, Communication Activities of Daily Living-Second edition, Direct Functional Status (p < 0.0001) and Object decision (p =0.0594), but no correlations were found between LTL and cognitive gains. Visual arts-mediated CAT effectively mitigates cellular aging, especially in men, by elongating LTL. These findings underscore the potential of non-pharmacological interventions in enhancing cognitive and functional status and general well-being in dementia care. Further research with larger and longer-term studies is essential for validation.
Keywords: Alzheimer’s disease; Cognitive Activation Therapy; DNA methylation age; biological aging; dementia; leukocytes telomere length; neurocognitive disorders; visual art.
Copyright © 2024 Campisi, Cannella, Celik, Gabelli, Gollin, Simoni, Ruaro, Fantinato and Pavanello.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants.J Int Neuropsychol Soc. 2020 Oct;26(9):906-917. doi: 10.1017/S1355617720000363. Epub 2020 Apr 28. J Int Neuropsychol Soc. 2020. PMID: 32342830 Free PMC article.
-
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.Exp Gerontol. 2012 Feb;47(2):179-82. doi: 10.1016/j.exger.2011.12.005. Epub 2011 Dec 22. Exp Gerontol. 2012. PMID: 22210159
-
Increased attrition of leukocyte telomere length in young adults is associated with poorer cognitive function in midlife.Eur J Epidemiol. 2016 Feb;31(2):147-57. doi: 10.1007/s10654-015-0051-4. Epub 2015 Jun 16. Eur J Epidemiol. 2016. PMID: 26076919 Free PMC article.
-
Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging.Future Cardiol. 2011 Nov;7(6):789-803. doi: 10.2217/fca.11.55. Future Cardiol. 2011. PMID: 22050065 Review.
-
Telomeres and cardiovascular disease risk: an update 2013.Transl Res. 2013 Dec;162(6):371-80. doi: 10.1016/j.trsl.2013.05.004. Epub 2013 Jun 7. Transl Res. 2013. PMID: 23748031 Review.
Cited by
-
Unveiling the geroprotective potential of Monarda didyma L.: insights from in vitro studies and a randomized clinical trial on slowing biological aging and improving quality of life.Geroscience. 2025 Jun;47(3):4253-4290. doi: 10.1007/s11357-025-01580-2. Epub 2025 Mar 10. Geroscience. 2025. PMID: 40064804 Free PMC article. Clinical Trial.
-
Exploring the Relationship between Telomere Length and Cognitive Changes in Post-COVID-19 Subjects.Biomedicines. 2024 Oct 10;12(10):2296. doi: 10.3390/biomedicines12102296. Biomedicines. 2024. PMID: 39457609 Free PMC article.
References
-
- Athanasopoulou S., Simos D., Charalampopoulou M., Tentolouris N., Kokkinos A., Bacopoulou F., et al. . (2021). Significant improvement of stress and aging biomarkers using a novel stress management program with the cognitive restructuring method “Pythagorean self-awareness intervention” in patients with type 2 diabetes mellitus and healthy adults. Mech. Ageing Dev. 198:111538. doi: 10.1016/j.mad.2021.111538, PMID: - DOI - PubMed
-
- Belsky D. W., Moffitt T. E., Cohen A. A., Corcoran D. L., Levine M. E., Prinz J. A., et al. . (2018). Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing? Am. J. Epidemiol. 187, 1220–1230. doi: 10.1093/aje/kwx346, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous